Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism

Carcinogenesis

Volumn 27, Issue 12, 2006, Pages 2528-2537

  Kalra, Jessica ^b   Shao, Qing ^a   Qin, Hong ^c   Thomas, Tamsin ^a   Alaoui Jamali, Moulay A ^d   Laird, Dale W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA1 INTEGRIN; CONNEXIN 26; CONNEXIN 43; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; MATRIGEL; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ARTICLE; BIOENGINEERING; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL COMMUNICATION; CELL STRAIN; CHIMERA; CONTROLLED STUDY; ENZYME INHIBITION; GAP JUNCTION; GENE EXPRESSION REGULATION; GOLGI COMPLEX; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CONNEXINS; FEMALE; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; RATS; VARIATION (GENETICS);

EID: 33750536492     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl110     Document Type: Article

References (60)

1. Goldberg,G.S., Valiunas,V. and Brink,P.R. (2004) Selective permeability of gap junction channels. Biochim. Biophys. Acta, 1662, 96-101.
2. Saez,J.C., Berthoud,V.M., Branes,M.C., Martinez,A.D. and Beyer,E.C. (2003) Plasma membrane channels formed by connexins: Their regulation and functions. Physiol. Rev., 83, 1359-1400.
3. Sohl,G. and Willecke,K. (2004) Gap junctions and the connexin protein family. Cardiovasc. Res., 62, 228-232.
4. Naus,C.C. (2002) Gap junctions and tumour progression. Can. J. Physiol. Pharmacol., 80, 136-141.
5. Jamieson,S., Going,J.J., D'Arcy,R. and George,W.D. (1998) Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J. Pathol., 184, 37-43.
6. Laird,D.W., Fistouris,P., Batist,G., Alpert,L., Huynh,H.T., Carystinos,G.D. and Alaoui-Jamali,M.A. (1999) Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res., 59, 4104-4110.
7. Qin,H., Shao,Q., Curtis,H., Galipeau,J., Belliveau,D.J., Wang,T., Alaoui-Jamali,M.A. and Laird,D.W. (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J. Biol. Chem., 277, 29132-29138.
8. Qin,H., Shao,Q., Thomas,T., Kalra,J., Alaoui-Jamali,M.A. and Laird,D.W. (2003) Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Commun. Adhes., 10, 387-393.
9. Monaghan,P., Clarke,C., Perusinghe,N.P., Moss,D.W., Chen,X.Y. and Evans,W.H. (1996) Gap junction distribution and connexin expression in human breast. Exper. Cell Res., 223, 29-38.
10. Monaghan,P. and Moss,D. (1996) Connexin expression and gap junctions in the mammary gland. Cell Biol. Int., 20, 121-125.
11. Locke,D. (1998) Gap junctions in normal and neoplastic mammary gland. J. Pathol., 186, 343-349.
12. Kang,K.S., Wilson,M.R., Hayashi,T., Chang,C.C. and Trosko,J.E. (1996) Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ. Health Perspect., 104, 192-200.
13. Lee,S.W., Tomasetto,C. and Sager,R. (1991) Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. Natl Acad. Sci. USA, 88, 2825-2829.
14. Lee,S.W., Tomasetto,C., Paul,D., Keyomarsi,K. and Sager,R. (1992) Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell. Biol., 118, 1213-1221.
15. Tomasetto,C., Neveu,M.J., Daley,J., Horan,P.K. and Sager,R. (1993) Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J. Cell. Biol., 122, 157-167.
16. Hirschi,K.K., Xu,C.E., Tsukamoto,T. and Sager,R. (1996) Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ., 7, 861-870.
17. Momiyama,M., Omori,Y., Ishizaki,Y., Nishikawa,Y., Tokairin,T., Ogawa,J. and Enomoto,K. (2003) Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci., 94, 501-507.
18. Goodenough,D.A. and Paul,D.L. (2003) Beyond the gap: Functions of unpaired connexon channels. Nat. Rev. Mol. Cell Biol., 4, 285-294.
19. Meyer,R.A., Laird,D.W., Revel,J.P. and Johnson,R.G. (1992) Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell. Biol., 119, 179-189.
20. Kojima,T., Spray,D.C., Kokai,Y., Chiba,H., Mochizuki,Y. and Sawada,N. (2002) Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line. Exp. Cell Res., 276, 40-51.
21. Duffy,H.S., John,G.R., Lee,S.C., Brosnan,C.F. and Spray,D.C. (2000) Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes. J. Neurosci., 20, RC114.
22. Kausalya,P.J., Phua,D.C. and Hunziker,W. (2004) Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: Binding to PDZ-domain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF. Mol. Biol. Cell, 15, 5503-5515.
23. Herve,J.C., Bourmeyster,N. and Sarrouilhe,D. (2004) Diversity in protein-protein interactions of connexins: Emerging roles. Biochim. Biophys. Acta, 1662, 22-41.
24. Giepmans,B.N. (2004) Gap junctions and connexin-interacting proteins. Cardiovasc. Res., 62, 233-245.
25. Laird,D.W. (2006) Life cycle of connexins in health and disease. Biochem. J., 394, 527-543.
26. Duflot-Dancer,A., Mesnil,M. and Yamasaki,H. (1997) Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene, 15, 2151-2158.
27. Yamasaki,H., Krutovskikh,V., Mesnil,M., Tanaka,T., Zaidan-Dagli,M.L. and Omori,Y. (1999) Role of connexin (gap junction) genes in cell growth control and carcinogenesis. Comptes Rendus de l Academie des Sciences Serie Iii, Sciences de la Vie, 322, 151-159.
28. Krutovskikh,V.A., Troyanovsky,S.M., Piccoli,C., Tsuda,H., Asamoto,M. and Yamasaki,H. (2000) Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene, 19, 505-513.
29. Zhang,Y.W., Kaneda,M. and Morita,I. (2003) The gap junction-independent tumor-suppressing effect of connexin 43. J. Biol. Chem., 278, 44852-44856.
30. Fu,C.T., Bechberger,J.F., Ozog,M.A., Perbal,B. and Naus,C.C. (2004) CCN3 (NOV) interacts with connexin43 in C6 glioma cells: Possible mechanism of connexin-mediated growth suppression. J. Biol. Chem., 279, 36943-36950.
31. Zhang,Y.W., Nakayama,K. and Morita,I. (2003) A novel route for connexin 43 to inhibit cell proliferation: Negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res., 63, 1623-1630.
32. el-Sabban,M.E. and Pauli,B.U. (1994) Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invas. Metastasis, 14, 164-176.
33. Kamibayashi,Y., Oyamada,Y., Mori,M. and Oyamada,M. (1995) Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis, 16, 1287-1297.
34. Saunders,M.M., Seraj,M.J., Li,Z., Zhou,Z., Winter,C.R., Welch,D.R. and Donahue,H.J. (2001) Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res., 61, 1765-1767.
35. Hamada,J., Nagayasu,H., Kawano,T., Mizutani,T., Nakata,D., Hosokawa,M. and Takeichi,N. (1998) Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body. Clin. Exp. Metastasis, 16, 291-298.
36. Shoji,A., Sakamoto,Y., Tsuchiya,T., Moriyama,K., Kaneko,T., Okubo,T., Umeda,M. and Miyazaki,K. (1997) Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1). Carcinogenesis, 18, 2093-2100.
37. El-Sabban,M.E. and Pauli,B.U. (1991) Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J. Cell Biol., 115, 1375-1382.
38. Ito,A., Katoh,F., Kataoka,T.R. et al. (2000) A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest., 105, 1189-1197.
39. Qin,H., Shao,Q., Igdoura,S.A., Alaoui-Jamali,M.A. and Laird,D.W. (2003) Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J. Biol. Chem., 278, 30005-30014.
40. Thomas,T., Telford,D. and Laird,D.W. (2004) Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J. Biol. Chem., 279, 19157-19168.
41. Mao,A.J., Bechberger,J., Lidington,D., Galipeau,J., Laird,D.W. and Naus,C.C. (2000) Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43. J. Biol. Chem., 275, 34407-34414.
42. Laird,D.W., Castillo,M. and Kasprzak,L. (1995) Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumor cells. J. Cell Biol., 131, 1193-1203.
43. Yeow,K.M., Phillips,B.W., Beaudry,P.P., Leco,K.J., Murphy,G. and Edwards,D.R. (2001) Expression of MMPs and TIMPs in mammalian cells. Methods Mol. Biol., 151, 181-189.
44. Fata,J.E., Leco,K.J., Moorehead,R.A., Martin,D.C. and Khokha,R. (1999) Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev. Biol., 211, 238-254.
45. Locke,D., Perusinghe,N., Newman,T., Jayatilake,H., Evans,W.H. and Monaghan,P. (2000) Developmental expression and assembly of connexins into homomeric and heteromeric gap junction hemichannels in the mouse mammary gland. J. Cell. Physiol., 183, 228-237.
46. Laird,D.W., Jordan,K. and Shao,Q. (2001) Expression and imaging of connexin-GFP chimeras in live mammalian cells. Methods Mol. Biol., 154, 135-142.
47. Contreras,J.E., Saez,J.C., Bukauskas,F.F. and Bennett,M.V. (2003) Functioning of cx43 hemichannels demonstrated by single channel properties. Cell Commun. Adhes., 10, 245-249.
48. Hernandez-Blazquez,F.J., Joazeiro,P.P., Omori,Y. and Yamasaki,H. (2001) Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. Exp. Cell Res., 270, 235-247.
49. Duffy,H.S., Delmar,M. and Spray,D.C. (2002) Formation of the gap junction nexus: Binding partners for connexins. J. Physiol. (Paris), 96, 243-249.
50. Giancotti,F.G. and Ruoslahti,E. (1999) Integrin signaling. Science, 285, 1028-1032.
51. Brakebusch,C. and Fassler,R. (2003) The integrin-actin connection, an eternal love affair. EMBO J., 22, 2324-2333.
52. Tate,A.W., Lung,T., Radhakrishnan,A., Lim,S.D., Lin,X. and Edlund,M. (2006) Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate, 66, 19-31.
53. El-Sabban,M.E., Sfeir,A.J., Daher,M.H., Kalaany,N.Y., Bassam,R.A. and Talhouk,R.S. (2003) ECM-induced gap junctional communication enhances mammary epithelial cell differentiation. J. Cell Sci., 116, 3531-3541.
54. White,D.E., Kurpios,N.A., Zuo,D., Hassell,J.A., Blaess,S., Mueller,U. and Muller,W.J. (2004) Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell, 6, 159-170.
55. Stetler-Stevenson,W.G., Hewitt,R. and Corcoran,M. (1996) Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin. Cancer Biol., 7, 147-154.
56. Kugler,A. (1999) Matrix metalloproteinases and their inhibitors. Anticancer Res., 19, 1589-1592.
57. Bartsch,J.E., Staren,E.D. and Appert,H.E. (2003) Matrix metalloproteinase expression in breast cancer. J. Surg. Res., 110, 383-392.
58. Morini,M., Mottolese,M., Ferrari,N., Ghiorzo,F., Buglioni,S., Mortarini,R., Noonan,D.M., Natali,P.G. and Albini,A. (2000) The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer, 87, 336-342.
59. Mesnil,M., Krutovskikh,V., Piccoli,C., Elfgang,C., Traub,O., Willecke,K. and Yamasaki,H. (1995) Negative growth control of HeLa cells by connexin genes: Connexin species specificity. Cancer Res., 55, 629-639.
60. Henzl,M.T., Thalmann,I., Larson,J.D., Ignatova,E.G. and Thalmann,R. (2004) The cochlear F-box protein OCP1 associates with OCP2 and connexin 26. Hear. Res., 191, 101-109.